JP2013523090A - 合成樟脳による望ましくない感覚効果の抑制 - Google Patents
合成樟脳による望ましくない感覚効果の抑制 Download PDFInfo
- Publication number
- JP2013523090A JP2013523090A JP2013500607A JP2013500607A JP2013523090A JP 2013523090 A JP2013523090 A JP 2013523090A JP 2013500607 A JP2013500607 A JP 2013500607A JP 2013500607 A JP2013500607 A JP 2013500607A JP 2013523090 A JP2013523090 A JP 2013523090A
- Authority
- JP
- Japan
- Prior art keywords
- camphor
- nicotine
- product
- flammable
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 title claims abstract description 100
- 230000001953 sensory effect Effects 0.000 title claims description 28
- 230000001629 suppression Effects 0.000 title 1
- 229940085790 synthetic camphor Drugs 0.000 title 1
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 97
- 229930008380 camphor Natural products 0.000 claims abstract description 97
- 229960000846 camphor Drugs 0.000 claims abstract description 97
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims abstract description 47
- 229960002715 nicotine Drugs 0.000 claims abstract description 47
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 47
- 235000019505 tobacco product Nutrition 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 230000000638 stimulation Effects 0.000 claims description 26
- 241000208125 Nicotiana Species 0.000 claims description 18
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 18
- 229940023486 oral product Drugs 0.000 claims description 17
- 239000013588 oral product Substances 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims 2
- 235000015218 chewing gum Nutrition 0.000 claims 2
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- 229940041678 oral spray Drugs 0.000 claims 1
- 239000000668 oral spray Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- 230000000694 effects Effects 0.000 description 20
- 206010006784 Burning sensation Diseases 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 235000019615 sensations Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000019504 cigarettes Nutrition 0.000 description 4
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 3
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 208000035824 paresthesia Diseases 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000005586 smoking cessation Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 101000764872 Homo sapiens Transient receptor potential cation channel subfamily A member 1 Proteins 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 102100026186 Transient receptor potential cation channel subfamily A member 1 Human genes 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012051 hydrophobic carrier Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- FVSJVBUYVLMHIZ-UHFFFAOYSA-N 4-oxo-4-[(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl)oxy]butanoic acid Chemical compound C1CC2(C)C(OC(=O)CCC(O)=O)CC1C2(C)C FVSJVBUYVLMHIZ-UHFFFAOYSA-N 0.000 description 1
- WWJLCYHYLZZXBE-UHFFFAOYSA-N 5-chloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=C2NC(=O)CC2=C1 WWJLCYHYLZZXBE-UHFFFAOYSA-N 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 1
- KGEKLUUHTZCSIP-UHFFFAOYSA-N Isobornyl acetate Natural products C1CC2(C)C(OC(=O)C)CC1C2(C)C KGEKLUUHTZCSIP-UHFFFAOYSA-N 0.000 description 1
- 241000030366 Scorpidinae Species 0.000 description 1
- 102000011040 TRPV Cation Channels Human genes 0.000 description 1
- 108010062740 TRPV Cation Channels Proteins 0.000 description 1
- 102000003566 TRPV1 Human genes 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 101150016206 Trpv1 gene Proteins 0.000 description 1
- 239000001940 [(1R,4S,6R)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Substances 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- RDWUNORUTVEHJF-UHFFFAOYSA-N bornyl formate Chemical compound C1CC2(C)C(OC=O)CC1C2(C)C RDWUNORUTVEHJF-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- -1 but in this example Chemical compound 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 108091008708 free nerve endings Proteins 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940071648 metered dose inhaler Drugs 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 229940015769 nicotine chewing gum Drugs 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035909 sensory irritation Effects 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 108091008691 sensory receptors Proteins 0.000 description 1
- 102000027509 sensory receptors Human genes 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003238 somatosensory effect Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/186—Treatment of tobacco products or tobacco substitutes by coating with a coating composition, encapsulation of tobacco particles
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
- A24B15/345—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring containing condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【選択図】 図5A
Description
末梢神経系の様々な神経末端上には、ニコチン性アセチルコリン受容体が存在し、刺激感(例えば、灼熱感)を脳に伝える役割を果たす。タバコに含まれるニコチンは、これらの受容体を活性化することができる。
図1及び図2に、ニコチンによる感覚刺激を樟脳で事前処置した効果についての調査結果を示す。ニコチン溶液を与える前に、ヒトボランティアの舌に樟脳を与えた。舌の無作為な面を選択し、エタノール/水溶液から得た0ppm、25ppm、50ppm又は100ppmの樟脳20マイクロリットルをストリップに垂らして(従って、それぞれ約0ピコグラム、約500ピコグラム、約1000ピコグラム又は約2000ピコグラム)30秒間与えた。その後、被験者は、0.1%、0.2%又は0.3%のニコチン溶液を一口すすり、口をゆすいで5秒後に吐き出した。その後、参加者に、舌のどちらの側の灼熱感が強いかを尋ねた。直後(5秒以内)(図1)及び30秒後(図2)の両方の時点で回答を集めた。対照には樟脳を与えず、基準を樟脳ゼロに設定した。
樟脳自体が感覚刺激を引き起こす閾値を判定するためのさらなる調査を行った。
表1:樟脳の刺激閾値の判定
噛みタバコを使用して、被験者の口内で知覚される灼熱感に樟脳が影響を与えるかどうかを判定するためのさらなる調査を行った。参加者に、2つのスヌースポーチ試料を与え、口の両側で同時に使用させた。一方の試料は樟脳を加えていない対照ポーチとし、他方には様々な濃度の樟脳を含めた(2.3ナノグラム、6ナノグラム、12ナノグラム、23ナノグラム、46ナノグラム及び69ナノグラム、それぞれタバコの重量ベースで25ppm、50ppm、100ppm、200ppm又は300ppmに対応する)。
樟脳以外のいくつかの成分も、樟脳と同様に作用してニコチンを介した活性化を抑制することにより、及び/又は樟脳の前駆体又は樟脳と同様に作用する別の化合物のように振る舞うことにより、樟脳と同じように機能すると見込まれる。このような前駆体は、ヒトによる消費時に(例えば、代謝酵素によって)活性体に変換されると見込まれる。
本発明者らは、無煙タバコ製品、又は薬用ニコチン製品及び/又は禁煙製品などの別のニコチン含有製品とともに有利に使用できる樟脳の担体系を発見した。このような担体系は、例えば無煙タバコ製品に添加すると、灼熱感、食道の異物感、しゃっくり及び吐き気を含む感覚刺激を軽減又は排除する。
本明細書で説明したように、無煙タバコのポーションには、ポーチ状タバコ(スヌースポーチと呼ばれることもある)及びポーチレスポーションがあり、このポーチレスポーションは、布及び/又は紙のラッパーが無く、使用前に個別の1回分に成形又は分割され、ユーザが使用量を決定する必要なく、事前分割されたタバコをユーザの口に入れることができるようにされた経口的に楽しめるタバコを含む。事前分割された、タバコなどの植物性素材のポーチレス製品は、同一出願人による米国特許出願公開第2008/0202533号、第2009/0038631号及び第2009/0301505号に記載されており、これらの特許出願の各々は引用により組み入れられる。ポーチ状ポーションは、例えば、米国特許出願公開第2007/0012328号及び第2007/0261707号に記載されており、これらの特許出願の各々も引用により組み入れられる。
製品は、様々な形で提供することができる。ある実施形態では、この製品が食用製品である。食用製品は、タブレット、ドロップ、スティック、チュアブルガム、スポンジ状素材、泡、クリーム、ペレット、繊維、錠剤、カプセル、ポーチ状製品、又はこれらの組み合わせの形をとることができる。食用製品のその他の例としては、タブレット、ガム、チョコレート、香味付きスポンジ、香味ストリップなどの、チュアブル又は非チュアブルタイプの食用形態が挙げられる。
12 内部充填材
14 多孔質ポーチラッパー
16 閉じ目
18 柔らかい端部
Claims (13)
- ニコチンと、
無香料油性担体に溶解した樟脳と、
を含むことを特徴とする不燃性経口製品。 - 前記樟脳が、約600ppm〜約1300ppmの濃度で存在する、
ことを特徴とする請求項1に記載の不燃性経口製品。 - 前記製品が薬用ニコチン製品である、
ことを特徴とする請求項1に記載の不燃性経口製品。 - 前記製品が無煙タバコ製品である、
ことを特徴とする請求項1に記載の不燃性経口製品。 - 前記製品が、水溶性の非架橋成分及び実質的に不水溶性の架橋成分を含むコーティングによって少なくとも部分的に封入されたタバコ粒子の集合体を含む、
ことを特徴とする請求項4に記載の不燃性経口製品。 - 前記製品が、透水性ラッパーに封入された無煙タバコを含むポーチを含む、
ことを特徴とする請求項4に記載の不燃性経口製品。 - 前記無香料油性担体に溶解した前記樟脳が、前記コーティング内に処理される、
ことを特徴とする請求項5に記載の不燃性経口製品。 - 前記無香料油性担体に溶解した前記樟脳が、前記ポーチの前記透水性ラッパー上のコーティング内に処理される、
ことを特徴とする請求項6に記載の不燃性経口製品。 - 前記ポーチが、前記透水性ラッパーの対向する層間の少なくとも1つの閉じ目と、該少なくとも1つの閉じ目の外側にある柔らかい端部とを有し、前記柔らかい端部が、前記対向する層間の未接着領域を含む、
ことを特徴とする請求項6に記載の不燃性経口製品。 - 前記薬用ニコチン製品が、チューインガム及び経口スプレーから成る群から選択される、
ことを特徴とする請求項3に記載の不燃性経口製品。 - 前記薬用ニコチン製品がチューインガムであり、前記無香料油性担体がワックスを含む、
ことを特徴とする請求項10に記載の不燃性経口製品。 - 前記樟脳が、前記ニコチンの消費によって生じる感覚刺激を軽減又は排除するのに効果的な量で存在する、
ことを特徴とする請求項1に記載の不燃性経口製品。 - 不燃性経口製品の作製方法であって、ニコチンと、無香料油性担体に溶解した樟脳とを組み合わせるステップを含む、
ことを特徴とする方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31825310P | 2010-03-26 | 2010-03-26 | |
US61/318,253 | 2010-03-26 | ||
PCT/IB2011/000994 WO2011117735A2 (en) | 2010-03-26 | 2011-03-28 | Inhibition of undesired sensory effects by the compound camphor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013523090A true JP2013523090A (ja) | 2013-06-17 |
JP5886823B2 JP5886823B2 (ja) | 2016-03-16 |
Family
ID=44486992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013500607A Active JP5886823B2 (ja) | 2010-03-26 | 2011-03-28 | 合成樟脳による望ましくない感覚効果の抑制 |
Country Status (14)
Country | Link |
---|---|
US (4) | US8952038B2 (ja) |
EP (1) | EP2552244B1 (ja) |
JP (1) | JP5886823B2 (ja) |
KR (1) | KR101760972B1 (ja) |
BR (1) | BR112012024364A2 (ja) |
CA (1) | CA2794638C (ja) |
DK (1) | DK2552244T3 (ja) |
EC (1) | ECSP12012251A (ja) |
MX (1) | MX340620B (ja) |
MY (1) | MY165804A (ja) |
PL (1) | PL2552244T3 (ja) |
RU (1) | RU2012145537A (ja) |
UA (1) | UA110029C2 (ja) |
WO (1) | WO2011117735A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015509702A (ja) * | 2011-12-14 | 2015-04-02 | センティエンズ,エルエルシー | 喫煙の化学受容を刺激するためのデバイス及び方法 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011117740A2 (en) | 2010-03-26 | 2011-09-29 | Philip Morris Products S.A. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
SE536491C2 (sv) * | 2012-03-26 | 2013-12-27 | Bionicotine Ab | Påse innehållande nikotin och en tuggummikomposition |
US9538782B2 (en) * | 2013-03-15 | 2017-01-10 | Altria Client Services Llc | Inhibition of sensory irritation during consumption of smokeless tobacco products using a combinatorial approach |
US10335378B2 (en) * | 2013-03-15 | 2019-07-02 | Altria Client Services Llc | Inhibition of central nervous system effects from smoking and sensory effects from smoking |
US10130120B2 (en) | 2013-03-15 | 2018-11-20 | Altria Client Services Llc | Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products |
US20150322451A1 (en) * | 2014-04-08 | 2015-11-12 | Altria Client Services Inc. | Tobacco having altered leaf properties and methods of making and using |
US20220087997A1 (en) * | 2020-09-22 | 2022-03-24 | Fertin Pharma A/S | Oral Antagonist Compositions For Nicotine Burning Relief |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5476551A (en) * | 1977-11-15 | 1979-06-19 | Int Flavors & Fragrances Inc | Trans*transsdeltaadamascon* mixture containing it at high rate*its manufacture and functional uses |
US4198309A (en) * | 1977-11-15 | 1980-04-15 | International Flavors & Fragrances Inc. | Use of trans, trans-Δ-damascone and mixtures containing 80% or more of trans, trans-Δ-damascone in augmenting or enhancing the aroma of a detergent |
JPS646216A (en) * | 1987-05-01 | 1989-01-10 | Eran Toransudaamaru Ltd | Therapy for abstinence symptom related to no smoking and medicine therefor |
JPH0139410B2 (ja) * | 1980-04-29 | 1989-08-21 | Int Flavors & Fragrances Inc | |
JPH0782588A (ja) * | 1993-09-14 | 1995-03-28 | Sanei Gen F F I Inc | 香気放出調整法 |
JP2002501768A (ja) * | 1998-02-09 | 2002-01-22 | ルソー リサーチ, インコーポレイテッド | ビタミンeを有するタバコ製品 |
JP2004500901A (ja) * | 2000-06-26 | 2004-01-15 | セラミ コンサルティング コーポレイション | タバコ及びタバコの煙からの求核性毒素の除去方法、薬剤及び装置 |
WO2004064811A1 (en) * | 2003-01-24 | 2004-08-05 | Magle Holding Ab | A composition material for transmucosal delivery |
JP2004229627A (ja) * | 2003-01-29 | 2004-08-19 | Yoshiaki Fujiyama | 鼻で吸うタバコ代用物 |
JP2004528035A (ja) * | 2001-05-01 | 2004-09-16 | ジョニー アール. ウィリアムズ | 無煙タバコ製品 |
CN1579258A (zh) * | 2004-05-18 | 2005-02-16 | 王自勇 | 一种新型鼻烟及其制作方法 |
JP2005508648A (ja) * | 2001-11-09 | 2005-04-07 | ベクター・タバコ・インコーポレーテッド | 炭でフィルターされた巻きタバコのメントール化のための組成物及び方法 |
US20070012328A1 (en) * | 2005-04-29 | 2007-01-18 | Philip Morris Usa Inc. | Tobacco pouch product |
US20080202533A1 (en) * | 2006-11-15 | 2008-08-28 | Philip Morris Usa Inc. | Moist tobacco product and method of making |
US20090032040A1 (en) * | 2007-03-30 | 2009-02-05 | Luzenberg Jr Robert S | Porous plastic smokeless tobacco substitutes |
JP2009148233A (ja) * | 2007-12-21 | 2009-07-09 | Japan Tobacco Inc | 喫煙物品 |
US20090301505A1 (en) * | 2008-02-08 | 2009-12-10 | Philip Morris Usa Inc. | Pre-portioned moist product and method of making |
JP2011529343A (ja) * | 2008-07-28 | 2011-12-08 | アール・ジエイ・レイノルズ・タバコ・カンパニー | 無煙タバコ製品およびプロセス |
US20120247492A1 (en) * | 2010-03-26 | 2012-10-04 | Philip Morris Usa Inc. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
WO2013111281A1 (ja) * | 2012-01-25 | 2013-08-01 | 日本たばこ産業株式会社 | たばこ臭口臭改善香料組成物 |
JP2014526278A (ja) * | 2011-09-22 | 2014-10-06 | アール・ジエイ・レイノルズ・タバコ・カンパニー | 半透明無煙タバコ製品 |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4378380A (en) | 1980-10-10 | 1983-03-29 | General Foods Corporation | Method for producing products enhanced with synthetic coffee grinder gas flavor |
US4351347A (en) * | 1981-03-25 | 1982-09-28 | International Flavors & Fragrances Inc. | Organoleptic uses of norbornyl ethers and esters |
USRE37934E1 (en) | 1986-08-28 | 2002-12-10 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system |
US6126963A (en) | 1986-08-28 | 2000-10-03 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
US5820876A (en) | 1986-08-28 | 1998-10-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system |
DE3827561C1 (ja) | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
US4959380A (en) | 1988-12-19 | 1990-09-25 | Wilson Jordan E | Method of treating people to stop smoking and composition |
US5167244A (en) * | 1990-01-19 | 1992-12-01 | Kjerstad Randy E | Tobacco substitute |
CA2053462A1 (en) | 1990-10-22 | 1992-04-23 | Yoshiaki Yano | Sticky composition for medical use |
DE4301782C1 (de) | 1993-01-23 | 1994-08-25 | Lohmann Therapie Syst Lts | Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit |
DE4341444C2 (de) | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
US5505958A (en) | 1994-10-31 | 1996-04-09 | Algos Pharmaceutical Corporation | Transdermal drug delivery device and method for its manufacture |
US5716621A (en) | 1996-07-03 | 1998-02-10 | Pharmadyn, Inc. | Nonocclusive drug delivery device and process for its manufacture |
DE19635676A1 (de) | 1996-09-03 | 1998-03-05 | Basf Ag | Feste geschäumte Wirkstoffzubereitungen |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
CA2216215A1 (en) | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
DE69833000T2 (de) | 1997-09-26 | 2006-09-07 | Noven Pharmaceuticals, Inc., Miami | Bio-klebemittelzusammensetzungen |
US20020017295A1 (en) | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
CN1044314C (zh) | 1997-12-01 | 1999-07-28 | 蒲邯名 | 健身香烟 |
JPH11313634A (ja) | 1998-03-12 | 1999-11-16 | Internatl Flavors & Fragrances Inc <Iff> | 呈味剤とその製造方法 |
US6270804B1 (en) | 1998-04-03 | 2001-08-07 | Biovail Technologies Ltd. | Sachet formulations |
US6103266A (en) | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
WO2000007603A2 (en) | 1998-08-04 | 2000-02-17 | Madash Llp | End modified thermal responsive hydrogels |
DE19843904A1 (de) | 1998-09-24 | 2000-03-30 | Basf Ag | Feste Dosierungsform mit polymerem Bindemittel |
US6165512A (en) | 1998-10-30 | 2000-12-26 | Fuisz Technologies Ltd. | Dosage forms containing taste masked active agents |
US7163705B2 (en) | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
TWI233810B (en) | 1999-02-19 | 2005-06-11 | Hisamitsu Pharmaceutical Co | A paster sheet |
DE19906979B4 (de) | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
US6183770B1 (en) | 1999-04-15 | 2001-02-06 | Acutek International | Carrier patch for the delivery of agents to the skin |
US7063859B1 (en) | 1999-04-28 | 2006-06-20 | Noven Pharmaceuticals, Inc. | Barrier film lined backing layer composition and method for topical administration of active agents |
US6277401B1 (en) | 1999-05-07 | 2001-08-21 | U.S. Dermatologics, Inc. | Drug delivery device |
DE19923427A1 (de) | 1999-05-21 | 2000-11-23 | Lohmann Therapie Syst Lts | Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen |
DE19932603A1 (de) | 1999-07-13 | 2001-01-25 | Gruenenthal Gmbh | Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren |
US6821953B1 (en) | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
US6582724B2 (en) | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
US20020004065A1 (en) | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
US6953593B2 (en) | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
AU2001261744A1 (en) * | 2000-05-19 | 2001-12-03 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
DE10032456A1 (de) | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
DE10053375C1 (de) | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
US6682757B1 (en) | 2000-11-16 | 2004-01-27 | Euro-Celtique, S.A. | Titratable dosage transdermal delivery system |
EP1366762B1 (en) | 2001-03-07 | 2015-12-30 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
US6668839B2 (en) | 2001-05-01 | 2003-12-30 | Jonnie R. Williams | Smokeless tobacco product |
US20040156886A1 (en) | 2001-06-12 | 2004-08-12 | Yasuhisa Kose | Sheet-like patch agent |
US6789546B2 (en) | 2001-06-26 | 2004-09-14 | Technion Research & Development Foundation Ltd. | Filters for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject |
US20040224012A1 (en) | 2001-10-05 | 2004-11-11 | Pichit Suvanprakorn | Topical application and methods for administration of active agents using liposome macro-beads |
US6893655B2 (en) | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
DE60105820D1 (de) | 2001-10-22 | 2004-10-28 | Pera Ivo E | Zusammensetzung zur Reduzierung oder Entwöhnung von Nikotinabhängigkeit |
GB0130518D0 (en) | 2001-12-21 | 2002-02-06 | Univ Gent | Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels |
US6750291B2 (en) | 2002-04-12 | 2004-06-15 | Pacific Corporation | Film-forming agent for drug delivery and preparation for percutaneous administration containing the same |
AR033748A1 (es) | 2002-05-15 | 2004-01-07 | Thalas Group Inc | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo |
JP4199485B2 (ja) | 2002-06-07 | 2008-12-17 | 久光製薬株式会社 | 貼付剤 |
SI1513532T1 (sl) | 2002-06-10 | 2007-08-31 | Euro Celtique Sa | Sistemi za odstranjevanje priprav za transdermalno oddajanje za preprečevanje zlorabe učinkovin, ki jih vsebujejo |
JP4792193B2 (ja) | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
SE0302947D0 (sv) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
US20040151771A1 (en) * | 2003-02-04 | 2004-08-05 | Gin Jerry B. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
US20040202708A1 (en) | 2003-04-14 | 2004-10-14 | 3M Innovative Properties Company | Transdermal drug delivery device with translucent inorganic barrier layer |
US20040219198A1 (en) | 2003-05-01 | 2004-11-04 | 3M Innovative Properties Company | Transdermal drug delivery device with multilayer backing |
WO2005011683A1 (ja) | 2003-08-04 | 2005-02-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
EP1684603A2 (en) | 2003-10-02 | 2006-08-02 | Vector Tobacco Ltd. | Tobacco product labeling system |
US20050118246A1 (en) | 2003-10-31 | 2005-06-02 | Wong Patrick S. | Dosage forms and layered deposition processes for fabricating dosage forms |
EP1682079B1 (en) | 2003-11-12 | 2007-04-25 | Symrise GmbH & Co. KG | Mixture with wintergreen odor and flavor |
DE10356925B4 (de) | 2003-12-05 | 2006-05-11 | Lts Lohmann Therapie-Systeme Ag | Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung |
US20050136112A1 (en) | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
US7923585B2 (en) | 2004-05-31 | 2011-04-12 | Takasago International Corporation | Menthol derivative and cooling agent composition comprising the same |
US20060078604A1 (en) | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
CA2585122A1 (en) | 2004-10-25 | 2006-05-04 | Schering Corporation | M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
US20060110415A1 (en) | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
CA2591817A1 (en) | 2004-12-22 | 2006-06-29 | Memory Pharmaceuticals Corporation | Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
JP2008525420A (ja) | 2004-12-23 | 2008-07-17 | マクニール−ピーピーシー・インコーポレーテツド | 感覚的きっかけ剤を有する、口で崩壊する薬用組成物 |
US7534454B2 (en) | 2004-12-28 | 2009-05-19 | Arun Kumar Karerat | Anti-cigarette herbal formulation as an antidote to tobacco |
US20070026025A1 (en) | 2005-04-12 | 2007-02-01 | Aquegel Cosmetics, Llc | Topical ointment and method for making and using same |
US20060228418A1 (en) | 2005-04-12 | 2006-10-12 | Aquegel Cosmetics, Llc | Topical ointment and method for making and using same |
US9044049B2 (en) | 2005-04-29 | 2015-06-02 | Philip Morris Usa Inc. | Tobacco pouch product |
US20090175982A1 (en) | 2005-05-23 | 2009-07-09 | Cadbury Adams Usa Llc., | Methods for managing release of one or more ingredients in an edible composition |
US7186958B1 (en) | 2005-09-01 | 2007-03-06 | Zhao Wei, Llc | Inhaler |
US20070074733A1 (en) | 2005-10-04 | 2007-04-05 | Philip Morris Usa Inc. | Cigarettes having hollow fibers |
JP2009529343A (ja) | 2006-03-16 | 2009-08-20 | ニコノヴァム エービー | ニコチンの迅速放出を提供するチューインガム組成物 |
US20080063748A1 (en) | 2006-09-08 | 2008-03-13 | Cadbury Adams Usa Llc. | Center-fill confectionery and chewing gum compositions containing suspended saccharide particles |
US20080102157A1 (en) | 2006-10-25 | 2008-05-01 | Steffen Hofacker | Flavored chewable foams and a process for their production |
US20080131467A1 (en) | 2006-11-30 | 2008-06-05 | Dennis Nelson | Film-coated solid dosage form |
US20080247957A1 (en) * | 2007-02-16 | 2008-10-09 | Drexel University | Advanced drug delivery strategy and platform for minimally-invasive treatment of liver cancer |
US8616221B2 (en) | 2007-02-28 | 2013-12-31 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
US20080299249A1 (en) | 2007-06-01 | 2008-12-04 | Cadbury Adams Usa Llc | Center-fill gum compositions incorporating triacetin |
US8901024B2 (en) | 2007-08-02 | 2014-12-02 | The Trustees Of Columbia University In The City Of New York | Ozone-treated carbon electrodes |
US8312886B2 (en) | 2007-08-09 | 2012-11-20 | Philip Morris Usa Inc. | Oral tobacco product having a hydrated membrane coating and a high surface area |
US20100018883A1 (en) * | 2008-07-28 | 2010-01-28 | Pankaj Patel | Smokeless tobacco products and processes |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
-
2011
- 2011-03-25 US US13/071,889 patent/US8952038B2/en active Active
- 2011-03-28 EP EP11723116.7A patent/EP2552244B1/en active Active
- 2011-03-28 UA UAA201211485A patent/UA110029C2/ru unknown
- 2011-03-28 KR KR1020127028126A patent/KR101760972B1/ko active IP Right Grant
- 2011-03-28 MX MX2012011150A patent/MX340620B/es active IP Right Grant
- 2011-03-28 MY MYPI2012004246A patent/MY165804A/en unknown
- 2011-03-28 JP JP2013500607A patent/JP5886823B2/ja active Active
- 2011-03-28 PL PL11723116T patent/PL2552244T3/pl unknown
- 2011-03-28 BR BR112012024364-0A patent/BR112012024364A2/pt not_active IP Right Cessation
- 2011-03-28 WO PCT/IB2011/000994 patent/WO2011117735A2/en active Application Filing
- 2011-03-28 CA CA2794638A patent/CA2794638C/en active Active
- 2011-03-28 RU RU2012145537/12A patent/RU2012145537A/ru unknown
- 2011-03-28 DK DK11723116.7T patent/DK2552244T3/en active
-
2012
- 2012-10-11 EC ECSP12012251 patent/ECSP12012251A/es unknown
-
2015
- 2015-01-07 US US14/591,485 patent/US10201180B2/en active Active
-
2019
- 2019-01-02 US US16/237,956 patent/US11388923B2/en active Active
-
2022
- 2022-05-24 US US17/751,959 patent/US20220361555A1/en active Pending
Patent Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5476551A (en) * | 1977-11-15 | 1979-06-19 | Int Flavors & Fragrances Inc | Trans*transsdeltaadamascon* mixture containing it at high rate*its manufacture and functional uses |
US4198309A (en) * | 1977-11-15 | 1980-04-15 | International Flavors & Fragrances Inc. | Use of trans, trans-Δ-damascone and mixtures containing 80% or more of trans, trans-Δ-damascone in augmenting or enhancing the aroma of a detergent |
US4211242A (en) * | 1977-11-15 | 1980-07-08 | International Flavors & Fragrances Inc. | Composition of matter comprising more than 50% trans, trans-Δ-damascone for augmenting or enhancing the aroma and taste of a smoking tobacco |
JPH0139410B2 (ja) * | 1980-04-29 | 1989-08-21 | Int Flavors & Fragrances Inc | |
JPS646216A (en) * | 1987-05-01 | 1989-01-10 | Eran Toransudaamaru Ltd | Therapy for abstinence symptom related to no smoking and medicine therefor |
JPH0782588A (ja) * | 1993-09-14 | 1995-03-28 | Sanei Gen F F I Inc | 香気放出調整法 |
JP2002501768A (ja) * | 1998-02-09 | 2002-01-22 | ルソー リサーチ, インコーポレイテッド | ビタミンeを有するタバコ製品 |
JP4447218B2 (ja) * | 2000-06-26 | 2010-04-07 | セラミ コンサルティング コーポレイション | タバコ及びタバコの煙からの求核性毒素の除去方法、薬剤及び装置 |
JP2004500901A (ja) * | 2000-06-26 | 2004-01-15 | セラミ コンサルティング コーポレイション | タバコ及びタバコの煙からの求核性毒素の除去方法、薬剤及び装置 |
JP2004528035A (ja) * | 2001-05-01 | 2004-09-16 | ジョニー アール. ウィリアムズ | 無煙タバコ製品 |
JP2005508648A (ja) * | 2001-11-09 | 2005-04-07 | ベクター・タバコ・インコーポレーテッド | 炭でフィルターされた巻きタバコのメントール化のための組成物及び方法 |
WO2004064811A1 (en) * | 2003-01-24 | 2004-08-05 | Magle Holding Ab | A composition material for transmucosal delivery |
JP5283334B2 (ja) * | 2003-01-24 | 2013-09-04 | マグル ホールディング エービー | 経粘膜伝達用組成物材料 |
JP2004229627A (ja) * | 2003-01-29 | 2004-08-19 | Yoshiaki Fujiyama | 鼻で吸うタバコ代用物 |
CN1579258A (zh) * | 2004-05-18 | 2005-02-16 | 王自勇 | 一种新型鼻烟及其制作方法 |
US20070012328A1 (en) * | 2005-04-29 | 2007-01-18 | Philip Morris Usa Inc. | Tobacco pouch product |
US20080202533A1 (en) * | 2006-11-15 | 2008-08-28 | Philip Morris Usa Inc. | Moist tobacco product and method of making |
US20090032040A1 (en) * | 2007-03-30 | 2009-02-05 | Luzenberg Jr Robert S | Porous plastic smokeless tobacco substitutes |
JP2009148233A (ja) * | 2007-12-21 | 2009-07-09 | Japan Tobacco Inc | 喫煙物品 |
US20090301505A1 (en) * | 2008-02-08 | 2009-12-10 | Philip Morris Usa Inc. | Pre-portioned moist product and method of making |
JP2011529343A (ja) * | 2008-07-28 | 2011-12-08 | アール・ジエイ・レイノルズ・タバコ・カンパニー | 無煙タバコ製品およびプロセス |
US20120247492A1 (en) * | 2010-03-26 | 2012-10-04 | Philip Morris Usa Inc. | Inhibition of sensory irritation during consumption of non-smokeable tobacco products |
JP2014526278A (ja) * | 2011-09-22 | 2014-10-06 | アール・ジエイ・レイノルズ・タバコ・カンパニー | 半透明無煙タバコ製品 |
WO2013111281A1 (ja) * | 2012-01-25 | 2013-08-01 | 日本たばこ産業株式会社 | たばこ臭口臭改善香料組成物 |
Non-Patent Citations (1)
Title |
---|
HILLIS: "POLYPHENOLS IN THE LEAVES OF EUCALYPTUS L'HERIT: A CHEMOTAXONOMIC SURVEY-I", PHYTOCHEMISTRY, vol. V5 N6, JPN5013004530, 1 November 1966 (1966-11-01), GB, pages 1075 - 1090, ISSN: 0003228650 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015509702A (ja) * | 2011-12-14 | 2015-04-02 | センティエンズ,エルエルシー | 喫煙の化学受容を刺激するためのデバイス及び方法 |
Also Published As
Publication number | Publication date |
---|---|
BR112012024364A2 (pt) | 2020-08-11 |
US8952038B2 (en) | 2015-02-10 |
RU2012145537A (ru) | 2014-05-10 |
WO2011117735A2 (en) | 2011-09-29 |
MY165804A (en) | 2018-04-27 |
ECSP12012251A (es) | 2012-11-30 |
US20120052021A1 (en) | 2012-03-01 |
US10201180B2 (en) | 2019-02-12 |
KR20130029067A (ko) | 2013-03-21 |
WO2011117735A3 (en) | 2012-05-18 |
CA2794638A1 (en) | 2011-09-29 |
US20190133175A1 (en) | 2019-05-09 |
PL2552244T3 (pl) | 2018-07-31 |
WO2011117735A8 (en) | 2011-11-10 |
DK2552244T3 (en) | 2018-03-19 |
US20220361555A1 (en) | 2022-11-17 |
EP2552244A2 (en) | 2013-02-06 |
MX340620B (es) | 2016-07-18 |
UA110029C2 (uk) | 2015-11-10 |
EP2552244B1 (en) | 2018-02-21 |
MX2012011150A (es) | 2013-03-05 |
CA2794638C (en) | 2018-05-29 |
KR101760972B1 (ko) | 2017-07-24 |
US20150126561A1 (en) | 2015-05-07 |
JP5886823B2 (ja) | 2016-03-16 |
US11388923B2 (en) | 2022-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5886823B2 (ja) | 合成樟脳による望ましくない感覚効果の抑制 | |
US20210378281A1 (en) | Inhibition of sensory irritation during consumption of non-smokeable tobacco products | |
Rose | Nicotine and nonnicotine factors in cigarette addiction | |
Tonnesen et al. | A double-blind trial of a nicotine inhaler for smoking cessation | |
JP5845194B2 (ja) | ニコチン含有ソフトゼラチントローチ | |
US3757798A (en) | Method of reducing dependence on tobacco | |
US4715387A (en) | Aerosol for use in the reduction of tobacco smoking | |
US20060162732A1 (en) | Method for making a nicotine toothpick | |
Kessler | Statement on nicotine-containing cigarettes | |
JPH06315367A (ja) | 喫煙抑制具 | |
Prignot | Pharmacological approach to smoking cessation | |
KR20230167356A (ko) | 산을 포함하는 향미가 있는 구강 파우치 니코틴 제품 | |
US20080017205A1 (en) | Method and Device for Releasing Flavor and Odor Substances | |
US20240164436A1 (en) | Nicotine Pouch Product Container, and a Method of Consuming Nicotine Pouch Products Therein | |
CN118766125A (zh) | 尼古丁液体制剂、其制备方法、雾化器及电子雾化装置 | |
CA1308351C (en) | Aerosol for use in the reduction of tobacco smoking | |
CN118766124A (zh) | 尼古丁液体制剂、其制备方法、雾化器及雾化装置 | |
Roopchandani et al. | Smoking cessation aids | |
FR2794981A1 (fr) | Oreiller anti-tabac | |
CZ280420B6 (cs) | Přípravek proti kouření | |
KR20030055457A (ko) | 금연보조 에어로졸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140328 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150316 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150616 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150716 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150817 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150914 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151214 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160112 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160212 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5886823 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |